Joost Kolkman

Joost Kolkman is a seasoned professional in the field of antibody discovery, currently serving as Director of Antibody Discovery at Galapagos since May 2024. Prior experience includes an Associate Director role at The Janssen Pharmaceutical Companies of Johnson & Johnson, where Joost developed innovative antibody-based strategies for respiratory viral diseases, leading multiple programs from early discovery to first-in-human (FIH) stages. As Principal Scientist at Janssen, Joost discovered a first-in-class, multi-specific antibody against influenza and led a successful collaboration with the Wilson lab for anti-influenza strategies. Joost's career also includes significant roles at Crucell and Ablynx, where responsibilities ranged from managing multi-pronged antibody discovery programs to developing technology for Nanobodies. Joost's educational background includes a PhD from Utrecht University and a Master's degree from Wageningen University & Research.